Journal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

Cerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY is a premier academic journal dedicated to the vital intersections of clinical psychology, neuropsychology, and psychiatry, offering researchers and clinicians a platform to publish cutting-edge findings and comprehensive reviews. Published by Oxford University Press, the journal aims to advance the understanding of the cognitive and psychological aspects of neurological conditions through rigorous empirical research and innovative methodologies. With an impressive range of quartile rankings, including Q2 in Clinical Psychology and Neuropsychology, the journal stands out for its commitment to enhancing clinical practices and improving patient outcomes. Although it does not offer open access, its reputation is underscored by a competitive impact factor, making it a critical resource for professionals in the field looking to stay informed on the latest developments. The journal has been a respected outlet since 1986, and as it continues into 2024, it remains a beacon for scholarly discourse in neuropsychology and mental health.

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

Alzheimer's Research & Therapy is a leading peer-reviewed journal published by BMC, dedicated to advancing our understanding of Alzheimer's disease and other neurodegenerative disorders. As an Open Access journal since 2009, it ensures that vital research findings are freely accessible to the global community, facilitating collaboration and innovation in the field. The journal's commitment to quality is evident in its impressive impact factor and its prestigious ranking in the Q1 quartile across multiple categories including Cognitive Neuroscience and Neurology. With a Scopus rank placing it in the top tier of both Neuroscience and Neurology disciplines, Alzheimer's Research & Therapy serves as a crucial platform for researchers, clinicians, and students who seek to contribute to the fight against Alzheimer's and related disorders. The journal covers a wide range of topics and actively encourages submissions that explore therapeutic strategies and innovative research methodologies, enriching the scientific dialogue in this vital area of health.

Applied Neuropsychology-Adult is a premier journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing the field of neuropsychology with a particular focus on adult populations. Since its inception in 2012, this journal has been a vital platform for disseminating innovative research, reviews, and clinical insights into the cognitive and psychological processes that influence adult behavior and functioning. With an impressive Scopus ranking, including Q3 status in both Developmental and Educational Psychology and Neuropsychology and Physiological Psychology, it demonstrates a commitment to high-quality scholarship that informs both clinical practice and theoretical understanding. Researchers, clinicians, and students alike will benefit from the journal's commitment to open access, providing broad access to valuable knowledge in the domain of neuropsychology. As it converges towards its 2024 milestone, Applied Neuropsychology-Adult continues to be an essential resource for those seeking to deepen their understanding of neuropsychological processes and their application in real-world settings.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.